Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia A Molodecky

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|March 6, 2025
Global withdrawal of Sabin oral poliovirus type 2 vaccine in 2016Natalia A Molodecky, Roland W Sutter,
Pathogens (Basel, Switzerland)|March 27, 2024
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global AcceptanceRoland W Sutter, Martin Eisenhawer, Natalia A Molodecky, et al.
Vaccine|March 19, 2021
Quantifying movement patterns and vaccination status of high risk mobile populations in Pakistan and Afghanistan to inform poliovirus risk and vaccination strategyNatalia A Molodecky, Asma Usman, Asif Javaid, et al.
Vaccine|October 11, 2021
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemicNatalia A Molodecky, Hamid Jafari, Rana M Safdar, et al.
Vaccine|January 28, 2020
Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptabilityCatherine Daly, Natalia A Molodecky, Meghana Sreevatsava, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|March 6, 2025
Global withdrawal of Sabin oral poliovirus type 2 vaccine in 2016Natalia A Molodecky, Roland W Sutter,
Pathogens (Basel, Switzerland)|March 27, 2024
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global AcceptanceRoland W Sutter, Martin Eisenhawer, Natalia A Molodecky, et al.
Vaccine|March 19, 2021
Quantifying movement patterns and vaccination status of high risk mobile populations in Pakistan and Afghanistan to inform poliovirus risk and vaccination strategyNatalia A Molodecky, Asma Usman, Asif Javaid, et al.
Vaccine|October 11, 2021
Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemicNatalia A Molodecky, Hamid Jafari, Rana M Safdar, et al.
Vaccine|January 28, 2020
Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptabilityCatherine Daly, Natalia A Molodecky, Meghana Sreevatsava, et al.
Pageof 1